Enzyme-based medical products

Enzymatica

Enzymatica is based in Lund, Sweden, and sells medical devices against infectious diseases. The company's first product is ColdZyme® Munspray, which is marketed for cold virus prophylaxis and anti-cold virus therapeutic.

Financials

ENZYMATICA

SEKm 2018 2019 2020
Sales 49 56 68
Sales growth (%) -17,9 15 21
EBITDA -35 -22 N/A
EBITDA margin (%) -36,9 -72,5 -39,1
EBIT adj -30 -44 -27
EBIT adj margin (%) -50,8 -91 -48,6
Pretax profit -44 -27 -27
EPS rep -0,47 -0,29 -0,29
EPS growth (%) -40,2 39,2 -1,1
EPS adj -0,47 -0,29 -0,29
DPS 0 0 0
EV/EBITDA (x) -6,7 -12 -13,3
EV/EBIT adj (x) -5,4 -9,7 -10,7
P/E (x) -4,6 -7,6 -7,5
P/E adj (x) -4,6 -7,6 -7,5
EV/sales (x) 4,9 4,7 4,3
FCF yield (%) -20,7 -12,1 -13
Dividend yield (%) 0 0 0
Net IB debt/EBITDA -1 -2,7 -4

Main shareholders

Enzymatica

Main shareholders Share capital % Voting shares % Verified
Mats K Andersson 11.1 % 11.1 % 12 Dec 2018
Gudmundur Palmasson 10.3 % 10.3 % 15 Mar 2017
Agusta Gudmundsdottir 9.8 % 9.8 % 31 Dec 2016
Danica Pension 7.9 % 7.9 % 31 Dec 2018
Håkan Roos 4.4 % 4.4 % 31 Dec 2018
Fibonacci Asset Management AB 4.3 % 4.3 % 31 Dec 2018
Avanza Pension 1.5 % 1.5 % 31 Dec 2018
Ulf Blom 1.4 % 1.4 % 31 Dec 2018
Jörgen Rexö 1.4 % 1.4 % 31 Dec 2018
Nordnet Pensionsförsäkring 1.2 % 1.2 % 31 Dec 2018
Source: Holdings by Modular Finance AB

Insider list

Enzymatica

Name
Abanico Invest AB
Abanico Invest AB
Fiddevången Aktiebolag
Mats Kristian Andersson
Abanico Invest AB
Bengt Baron
Therese Filmersson
Bengt Baron
Andersson & Co Invest AB
Fredrik Lindberg
Show More